Features
1 - 15 of 665 results
James Hulse, Ph.D. and Chris Cox, Ph.D. , EMD Millipore
May 6, 2013
Evaluating the pharmacodynamics of biosimilar monoclonal antibodies
Read More »
Andrei Karelin, Maxim Belotserkovskiy, Veronika Khokhlova and Akhil Kumar, PSI CRO AG
May 6, 2013
Algorithms can reduce the role of subjective factors
Read More »
Mario DiPaola, Blue Stream Laboratories
May 6, 2013
How to best outsource the development of biosimilars
Read More »
Byran Cox, Pharma Tech Industries
May 6, 2013
Vertical integration & turnkey contract manufacturing
Read More »
Jeff Schwartz, Avior Computing Corp.
May 6, 2013
A painful manual process improving with automation
Read More »
Carol Mooney, West Pharmaceutical Services, Inc.
May 6, 2013
What drugmakers need to know about the Revised USP General Chapter <1> Injections Standard
Read More »
Edward Grimm, PL Developments
May 6, 2013
Contract packaging becomes a competitive advantage
Read More »
Gil Y. Roth, Contractu2008Pharma
May 6, 2013
Parexel’s CEO talks about the MassBio award and the digital future
Read More »
Gil Y. Roth, Contract Pharma
April 3, 2013
Novartis head Chris Snook talks about the company’s new bio-facility
Read More »
John LaMattina , PureTech Ventures
April 3, 2013
Pipeline transparency makes it hard to hide negative clinical trials
Read More »
Wayland Rushing and Thomas J. Wilson, ABC Laboratories and Synta Pharmaceuticals
April 3, 2013
Best practices for outsourcing drug development
Read More »
Maricela Ostrand, Randstad Pharma
April 3, 2013
Industry shifts, competition for talent require proactive workforce planning
Read More »
1 - 15 of 665 results
